$Veracyte (VCYT.US)$ Veracyte announced that it has begun ro...

Veracyte announced that it has begun rolling out its long-awaited nasal swab test for lung cancer at a limited number of clinical sites, as the company continues to accumulate data to support its future full commercial rollout.

The company also published recent findings showing that the Percepta Genomic test can more accurately group patients based on their risk of developing tumors and suspicious lung nodules.